Beryl Drugs25.86
+1.02 (+4.11%)

Beryl Drugs Share Price

25.86+1.02 (+4.11%)
+10.28% past 1 Year

Corporate filings & documents

Announcements

CLOSURE OF TRADING WINDOW
6 days ago
CLOSURE OF TRADING WINDOW
6 days ago
VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER 2026
6 days ago
VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER 2026
6 days ago
PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING
1 week ago
PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING
1 week ago
considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD.
1 week ago
considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD.
1 week ago
OUTCOME OF 33RD ANNUAL GENERAL MEETING
1 week ago
OUTCOME OF 33RD ANNUAL GENERAL MEETING
1 week ago
NEWSPAPER PUBLICATION OF 33RD ANNUAL GENERAL MEETING NOTICE
1 month ago
ANNUAL REPORT 2025-2026
1 month ago
ANNUAL REPORT 2025-2026
1 month ago
33RD ANNUAL GENERAL MEETING NOTICE
1 month ago
33RD ANNUAL GENERAL MEETING NOTICE
1 month ago
EVOTING DATES FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING
1 month ago
RECORD DATE
1 month ago
INTIMATION OF ANNUAL BOOK CLOSURE
1 month ago
OUTCOME OF BOARD MEETING
1 month ago
OUTCOME OF BOARD MEETING
1 month ago
Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve approve board report and other matters related to 33rd annual general meeting of the company
1 month ago
Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve approve board report and other matters related to 33rd annual general meeting of the company
1 month ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
1 month ago
NEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month ago
NEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month ago
UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month ago
UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
1 month ago
OUTCOME OF BOARD MEETING
1 month ago
OUTCOME OF BOARD MEETING
1 month ago
Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026
2 months ago
Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended 30th june 2026
2 months ago
TEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.
2 months ago
TEMPORARY UNAVAILABILITY OF THE COMPANYS WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.
2 months ago
CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018
3 months ago
CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS 2018
3 months ago
NON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE 2026
3 months ago
NON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE 2026
3 months ago
CLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30.06.2026
3 months ago
CLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30.06.2026
3 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months ago
CHANGE IN REGISTERED OFFICE OF THE COMPANY FROM 133 KANCHAN BAGH INDORE TO 29 NEER NAGAR MAYANK WATER PARK ROAD BICHOLI INDORE WITHIN LOCAL LIMITS OF SAME CITY
3 months ago
CHANGE IN REGISTERED OFFICE OF THE COMPANY FROM 133 KANCHAN BAGH INDORE TO 29 NEER NAGAR MAYANK WATER PARK ROAD BICHOLI INDORE WITHIN LOCAL LIMITS OF SAME CITY
3 months ago
OUTCOME OF BOARD MEETING
3 months ago
OUTCOME OF BOARD MEETING
3 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sudhir Sethi
3 months ago

Concalls & investor presentations

Empty box

No presentations found

Beryl Drugs Ltd Share Price Today

The Beryl Drugs Ltd share price today is ₹25.99. During the trading session, the Beryl Drugs Ltd share price opened at ₹25 and recorded an intraday high of ₹26.9 and a low of ₹24.05. Last closing price was ₹25.65. Over the past 52 weeks, the Beryl Drugs Ltd share price has ranged between ₹15.92 and ₹27.6. The current Beryl Drugs Ltd stock price reflects real-time market activity based on executed trades on the exchange.